🇺🇸 Hydrocodone ER in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Arthralgia — 1 report (10%)
2. Blood Potassium Increased — 1 report (10%)
3. Body Temperature Increased — 1 report (10%)
4. Burning Sensation — 1 report (10%)
5. Cardiac Arrest — 1 report (10%)
6. Cerebrovascular Accident — 1 report (10%)
7. Dependence — 1 report (10%)
8. Dizziness — 1 report (10%)
9. Headache — 1 report (10%)
10. Lymphadenopathy — 1 report (10%)

Source database →

Frequently asked questions

Is Hydrocodone ER approved in United States?

Hydrocodone ER does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Hydrocodone ER in United States?

Teva Branded Pharmaceutical Products R&D, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.